121 related articles for article (PubMed ID: 34627772)
1. AHNAK2 promotes thyroid carcinoma progression by activating the NF-κB pathway.
Ye R; Liu D; Guan H; AiErken N; Fang Z; Shi Y; Zhang Y; Wang S
Life Sci; 2021 Dec; 286():120032. PubMed ID: 34627772
[TBL] [Abstract][Full Text] [Related]
2. Silencing of AHNAK2 restricts thyroid carcinoma progression by inhibiting the Wnt/β-catenin pathway.
Lin QY; Qi QL; Hou S; Chen Z; Jiang N; Zhang L; Lin CH
Neoplasma; 2021 Sep; 68(5):1063-1071. PubMed ID: 34374294
[TBL] [Abstract][Full Text] [Related]
3.
Xu M; Wen J; Xu Q; Li H; Lin B; Bhandari A; Qu J
Curr Cancer Drug Targets; 2024; 24(2):220-229. PubMed ID: 36089788
[TBL] [Abstract][Full Text] [Related]
4. AHNAK Nucleoprotein 2 Performs a Promoting Role in the Proliferation and Migration of Uveal Melanoma Cells.
Li M; Liu Y; Meng Y; Zhu Y
Cancer Biother Radiopharm; 2019 Dec; 34(10):626-633. PubMed ID: 31621397
[TBL] [Abstract][Full Text] [Related]
5. Down-Regulation of AHNAK2 Inhibits Cell Proliferation, Migration and Invasion Through Inactivating the MAPK Pathway in Lung Adenocarcinoma.
Wang DW; Zheng HZ; Cha N; Zhang XJ; Zheng M; Chen MM; Tian LX
Technol Cancer Res Treat; 2020; 19():1533033820957006. PubMed ID: 33000678
[TBL] [Abstract][Full Text] [Related]
6. The CXCL12-CXCR4 axis promotes migration, invasiveness, and EMT in human papillary thyroid carcinoma B-CPAP cells via NF-κB signaling.
Lin Y; Ma Q; Li L; Wang H
Biochem Cell Biol; 2018 Oct; 96(5):619-626. PubMed ID: 29316404
[TBL] [Abstract][Full Text] [Related]
7. HAX-1 promotes the migration and invasion of hepatocellular carcinoma cells through the induction of epithelial-mesenchymal transition via the NF-κB pathway.
Hu YL; Feng Y; Ma P; Wang F; Huang H; Guo YB; Li P; Mao QS; Xue WJ
Exp Cell Res; 2019 Aug; 381(1):66-76. PubMed ID: 31047882
[TBL] [Abstract][Full Text] [Related]
8. AHNAK2 Regulates NF-κB/MMP-9 Signaling to Promote Pancreatic Cancer Progression.
Tang NN; Xu RB; Jiang B; Zhang HL; Wang XS; Chen DD; Zhu JJ
Biochem Genet; 2024 Jun; ():. PubMed ID: 38864962
[TBL] [Abstract][Full Text] [Related]
9. MiR-182 promotes cancer invasion by linking RET oncogene activated NF-κB to loss of the HES1/Notch1 regulatory circuit.
Spitschak A; Meier C; Kowtharapu B; Engelmann D; Pützer BM
Mol Cancer; 2017 Jan; 16(1):24. PubMed ID: 28122586
[TBL] [Abstract][Full Text] [Related]
10. BRAFV600E mutation, TIMP-1 upregulation, and NF-κB activation: closing the loop on the papillary thyroid cancer trilogy.
Bommarito A; Richiusa P; Carissimi E; Pizzolanti G; Rodolico V; Zito G; Criscimanna A; Di Blasi F; Pitrone M; Zerilli M; Amato MC; Spinelli G; Carina V; Modica G; Latteri MA; Galluzzo A; Giordano C
Endocr Relat Cancer; 2011 Dec; 18(6):669-85. PubMed ID: 21903858
[TBL] [Abstract][Full Text] [Related]
11. AHNAK2 is a Novel Prognostic Marker and Oncogenic Protein for Clear Cell Renal Cell Carcinoma.
Wang M; Li X; Zhang J; Yang Q; Chen W; Jin W; Huang YR; Yang R; Gao WQ
Theranostics; 2017; 7(5):1100-1113. PubMed ID: 28435451
[TBL] [Abstract][Full Text] [Related]
12. Smad Ubiquitination Regulatory Factor 1 (Smurf1) Promotes Thyroid Cancer Cell Proliferation and Migration via Ubiquitin-Dependent Degradation of Kisspeptin-1.
Yan C; Su H; Song X; Cao H; Kong L; Cui W
Cell Physiol Biochem; 2018; 49(5):2047-2059. PubMed ID: 30244247
[TBL] [Abstract][Full Text] [Related]
13. Src Promotes Metastasis of Human Non-Small Cell Lung Cancer Cells through Fn14-Mediated NF-κB Signaling.
Wang W; Liu F; Wang C; Wang C; Tang Y; Jiang Z
Med Sci Monit; 2018 Mar; 24():1282-1294. PubMed ID: 29500337
[TBL] [Abstract][Full Text] [Related]
14. The role of P62 in the development of human thyroid cancer and its possible mechanism.
Mao Y; Deng SJ; Su YJ; Diao C; Peng Y; Ma JF; Cheng RC
Cancer Genet; 2021 Aug; 256-257():5-16. PubMed ID: 33780725
[TBL] [Abstract][Full Text] [Related]
15. Odd-skipped related transcription factor 1 (OSR1) suppresses tongue squamous cell carcinoma migration and invasion through inhibiting NF-κB pathway.
Chen W; Wu K; Zhang H; Fu X; Yao F; Yang A
Eur J Pharmacol; 2018 Nov; 839():33-39. PubMed ID: 30244004
[TBL] [Abstract][Full Text] [Related]
16. Twist1 regulates the epithelial-mesenchymal transition via the NF-κB pathway in papillary thyroid carcinoma.
Lv N; Shan Z; Gao Y; Guan H; Fan C; Wang H; Teng W
Endocrine; 2016 Mar; 51(3):469-77. PubMed ID: 26289126
[TBL] [Abstract][Full Text] [Related]
17. AHNAK2 is a novel prognostic marker and correlates with immune infiltration in papillary thyroid cancer: Evidence from integrated analysis.
Zheng L; Li S; Zheng X; Guo R; Qu W
Int Immunopharmacol; 2021 Jan; 90():107185. PubMed ID: 33218938
[TBL] [Abstract][Full Text] [Related]
18. Neuropilin-1 promotes epithelial-to-mesenchymal transition by stimulating nuclear factor-kappa B and is associated with poor prognosis in human oral squamous cell carcinoma.
Chu W; Song X; Yang X; Ma L; Zhu J; He M; Wang Z; Wu Y
PLoS One; 2014; 9(7):e101931. PubMed ID: 24999732
[TBL] [Abstract][Full Text] [Related]
19. BRAFV600E promotes invasiveness of thyroid cancer cells through nuclear factor kappaB activation.
Palona I; Namba H; Mitsutake N; Starenki D; Podtcheko A; Sedliarou I; Ohtsuru A; Saenko V; Nagayama Y; Umezawa K; Yamashita S
Endocrinology; 2006 Dec; 147(12):5699-707. PubMed ID: 16959844
[TBL] [Abstract][Full Text] [Related]
20. Correlation between prognostic indicator AHNAK2 and immune infiltrates in lung adenocarcinoma.
Zheng M; Liu J; Bian T; Liu L; Sun H; Zhou H; Zhao C; Yang Z; Shi J; Liu Y
Int Immunopharmacol; 2021 Jan; 90():107134. PubMed ID: 33168407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
